Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Novocure Stock Is Sinking Today

TheMotleyFool

0 0

Why Novocure Stock Is Sinking Today: https://g.foolcdn.com/editorial/images/715825/novocure-image-2-smiling-people.jpg

Shares of Novocure (NASDAQ: NVCR) are sinking today, down by 15.4% as of 10:44 a.m. ET. The decline came after the company announced its preliminary full-year and fourth-quarter 2022 net revenue numbers.

Novocure said that its total preliminary net revenue for 2022 rose 1% year over year to $537.8 million. Its total preliminary net revenue for Q4 is $128.4 million, down 3.6% from the prior-year period.

Investors were excited last week after Novocure announced good news from a late-stage study of its Tumor Treating Fields (TTFields). The company reported that TTFields met the primary endpoint of the study by improving overall survival in patients with advanced non-small cell lung cancer (NSCLC).

Source Fool.com

Like: 0

NVCR

Share